Back Refine search Reset
Please choose a search criteria from below
Filters Clear all
Specialties
Treatments

44 results found for 'Haematology' in London, UK

Sort by:
Showing 1 - 10 of 44 results
Expert in: Haematology
Recommended by 1 specialist
29 years of experience

Dr Panos Kottaridis is a Consultant Haematologist in Leukaemia and Bone Marrow Transplantation at University College London Hospitals NHS.

His main academic and clinical interests focus on prognostication of acute myeloid leukaemia (AML), bone marrow transplantation, late effects of chemotherapy/ bone marrow transplantation, fertility in recipients of chemotherapy and immunotherapy of haematological malignancies (i.e. monoclonal antibodies, CAR-T cells).

Dr Kottaridis is a member of the National Cancer Research Network (Former MRC) working party for AML. He has published more than 74 papers in peer-reviewed journals and more than 4000 scientific papers have cited his work; he has also contributed with two chapters in Haematology textbooks.

Dr Kottaridis is an enthusiastic teacher and lecturer having given more than 200 lectures and presentations in national and international meetings.

It is important that HCA is transparent about our relationship with those doctors who provide us with clinical guidance on delivering the best possible care to patients and operating our hospitals safely and efficiently. We set out here some of the ways in which we work together and the amount we pay this doctor for such services.


Diseases, Medical Tests and Treatments
  • Bone Marrow Transplantation
  • Immunotherapy
  • Acute Myeloid Leukaemia (AML)
  • Bone Marrow Transplantation
  • Treating Haematological Malignancies with Immunotherapy
  • Late Effects of Chemotherapy/ Bone Marrow Transplantation
  • Fertility in Recipients of Chemotherapy 
Read more
Expert in: Haematology
24 years of experience

Dr Charalampia Kyriakou is a Consultant Haematologist at University College London Hospitals NHS Trust (UCLH), London North West University Healthcare NHS Trust (LNWH) and the Royal National Orthopaedic Hospital Myeloma Spinal Service. She also prides a first-class service with HCA Healthcare, where she helps patients suffering from multiple myeloma, lymphoma and other blood cancers. She also specialises in stem cell transplantation for multiple, lymphoma and for patients with multiple sclerosis.

She offers a holistic approach to treatments, with her patients best interest at heart at all times. She is dedicated to improving outcomes and wellbeing for her patients.

After qualifying with a Medical Degree, she completed an extensive rotational training scheme in haematology at University College London Hospital before being appointed as Consultant. Since then she has been appointed to numerous committees and teams, including the stem cell transplantation team for Myeloma at UCLH, the Myeloma Spinal Service at RNOH and is the Lead for Myeloma and Lymphoma services at LNWH.

She is heavily involved in national and international clinical trials with a passion for improving cancer outcomes. During her career, she has published over 50 peer-reviewed papers and contributed to two chapters in haematology textbooks.


Diseases, Medical Tests and Treatments
  • Chemotherapy for haematological blood cancer conditions
  • Stem Cell Transplantation for Myeloma, Lymphoma and Multiple Sclerosis
  • Multiple Myeloma paraproteinemias
  • Lymphoma (Non-Hodgkin's and Hodgkin's Lymphoma)
  • Transplation for Myeloma and Lymphoma
Read more
Expert in: Haematology
22 years of experience

Dr Rakesh Popat is a Consultant Haematologist with specialist expertise in Multiple Myeloma. His NHS base is at University College Hospital, London where he leads the Myeloma Clinical Trials Program and is the Cancer Program lead for the NIHR UCLH Clinical Research Facility. He has particular experience with novel treatments including immunotherapies such as CAR-T cell therapy and new antibody approaches.

Dr Popat is on the leadership boards of the UK Myeloma Forum, The UK Myeloma Research Alliance and the European Myeloma Network. In addition, he is the Haematology lead for the North Thames Clinical Research Network. He completed a PhD in novel treatments for Myeloma and was awarded a Fellowship to attend the Dana Farber Cancer Institute, Boston USA as part of this.


Diseases, Medical Tests and Treatments

All aspects of Multiple Myeloma, with a specific interest in new treatments including immunotherapies

Read more
Expert in: Haematology
35 years of experience

Professor Kwee Lan Yong is a specialist in Haematological Oncology and one of the leading specialists in the treatment of patients with multiple myeloma.

She completed her medical training at Oxford University and University College London (UCL), before undertaking doctoral studies at UCL and was awarded a PhD in 1993 for her research into growth factors. In 1999 she was appointed as a Senior Lecturer and Honorary Consultant at UCL, before becoming Clinical and Academic Lead in Multiple Myeloma at University College Hospital and the North London Cancer Network (NLCN).


Dr Yong runs an active trials programme and a laboratory research programme. She has published more than 60 original papers in peer-reviewed journals, and is a reviewer for international journals and grant-awarding bodies. She runs the undergraduate course for Haematology at UCL Medical School and regularly speaks at international conferences.


Diseases, Medical Tests and Treatments
  • Chemotherapy 
  • Haematological Stem Cell Transplantation

Myeloma 

Read more
Expert in: Haematology
42 years of experience

Dr Robert Marcus, MA, FRCP, FRCPath is a Consultant Haematologist working at LOC Harley St and Chelsea, and London Bridge Hospital.

He qualified in Medicine from University College Hospital Medical School in London in 1977 and specialised in haematology at the Royal Postgraduate Medical School and the Royal Free Hospital.He was appointed Consultant Haematologist in Addenbrooke’s Hospital in Cambridge in 1987 where he established the regional bone marrow transplant unit and developed particular expertise in lymphoma and other haematological malignancies. He moved to Kings College Hospital in 2008 where he remained as Consultant Haematologist until 2017 when he left the NHS after 40 years service, 30 at Consultant level, to work solely in the private sector

Dr Marcus’ research interests include the development of novel therapies for lymphoma, where he has been Chief investigator in a large number of practice-changing studies. More recently he developed further expertise in the management of Cerebral Lymphoma and Lymphoproliferative disorders in patients with HIV and after organ transplantation.

Dr Marcus was chairman of the NCRI low-grade lymphoma working for the party and has been an examiner for the Royal College of Pathologists. He is a medical advisor to ' Lymphoma Action' and Vice President of 'Leukaemia Care'.

Dr Marcus has authored more than 150 peer-reviewed manuscripts and reviews, including national guidelines on follicular, cerebral and post-transplant lymphoma. He has co-edited or contributed to 4 books, including the most recent edition of Post Graduate Haematology and textbooks on Multiple Myeloma and Lymphoma


Diseases, Medical Tests and Treatments
  • Chemotherapy 
  • Haemato-Oncology:

Lymphoma , Hodgkins Disease

Lymphoproliferative disorders

Myeloma 

General Haematology

Iron Deficiency 

Iron overload /Haemochromatosis 



Read more
Expert in: Haematology
36 years of experience

Professor John Pasi Consultant Haematologist specialising in haemostasis and thrombosis, with a particular clinical interest in thrombosis due to an inherited condition or resulting from age-related and chronic disease-related changes during later life. He also treats patients with a variety of bleeding problems including genetic conditions such as von Willebrand disease and haemophilia.

Professor Pasi graduated in medicine from the University of Birmingham in 1983 completing specialist training in haematology at Birmingham Children’s Hospital. He was awarded a PhD for his research and in 1993 was appointed as Consultant Haematologist and Honorary Senior Lecturer at the Royal Free Hospital and School of Medicine, where he remained until 1999. He was then appointed Professor of Haematology at the University of Leicester, as well as Head of Haematology Services at the University Hospitals of Leicester NHS Trust.

Outside his clinical work, he is keen to promote good practice in haematology, helping to develop various national guidelines concerned with how haemostatic and thrombotic disorders should be optimally treated.


Diseases, Medical Tests and Treatments

Treatment of:

  • Blood coagulation
  • Thrombosi
  • Bleeding disorders
  • Venous thromboembolism (DVT and PE)
  • Anticoagulation
  • Haemostasis
  • Thrombosis
  • Inherited clotting disorders
  • Von Willebrand disease
  • Haemophilia
  • Pulmonary thrombo-embolism
  • Bleeding disorders
Read more
Expert in: Haematology
39 years of experience

Professor Stephen Mackinnon is a Consultant Haematologist at HCA UK at University College Hospital. He specialises in haemato-oncology and has extensive experience in the diagnosis, management and treatment of leukaemia, myeloma and lymphoma.

He attended medical school at the University of Glasgow and then trained in internal medicine and haemato-oncology in Glasgow. He then undertook a transplant fellowship at the Hammersmith Hospital in London where he developed an interest in graft-versus-leukaemia reactions. In 1990 he moved to Memorial Sloan Kettering Cancer Center in New York to continue this work in both the clinic and the lab. His work included making the use of donor lymphocytes less toxic by limiting the T cell dose administered to transplant recipients allowing separation of graft-versus-leukaemia responses from graft-versus-host disease. In 1995 he returned to London to lead the bone marrow and stem cell program at University College London.

In recent years, Professor Mackinnon has developed an interest in novel conditioning regimens. Current research interests include adoptive immunotherapy and immune reconstitution following allogeneic stem cell transplantation, a programme which has resulted in world class transplant outcomes for patients with leukaemia and lymphoma.

  

Diseases, Medical Tests and Treatments

  • Chemotherapy
  • Bone Marrow / Stem Cell Transplantation
  • Leukaemia
  • Lymphoma
  • Myeloma
  • Myelodysplasia
  • Myelofibrosis

It is important that HCA is transparent about our relationship with those doctors who provide us with clinical guidance on delivering the best possible care to patients and operating our hospitals safely and efficiently. We set out here some of the ways in which we work together and the amount we pay this doctor for such services.

Read more
Dr Neil Rabin

Dr Neil Rabin

1.28 miles

Dr Neil Rabin

1.28 miles
Expert in: Haematology
23 years of experience

Dr Neil Rabin is a Consultant Haematologist who works at University College Hospital. His special interests include clinical trials evaluating new treatments for myeloma at diagnosis and at relapse.


Diseases, Medical Tests and Treatments
  • Clinical trials evaluating new treatments for myeloma at diagnosis and at relapse
Read more
Expert in: Haematology
18 years of experience

Dr Ali Rismani is a Consultant Haematologist based in London. He graduated from Imperial College Medical School in 2001, completing his specialist haematology training at Addenbrooke’s Hospital, Cambridge University Hospitals and UCLH.

Dr Rismani specialises in the diagnosis and management of blood cancers, specifically in the treatment of myeloma, lymphoma and chronic lymphocytic leukaemia (CLL). He also sees patients with general haematology disorders.

In addition to his clinical work, Dr. Rismani also has particular expertise and a research interest in Waldenstrom’s Macroglobulinaemia, also known as Lymphoplasmacytic Lymphoma. He has been part of a number of international trials investigating this rare type of non-Hodgkin B cell lymphoma and has had his work published in a number of peer reviewed journals.

Read more
Expert in: Haematology
23 years of experience

Dr Farrukh Shah is a consultant haematologist currently based at the Whittington hospital in London. Her area of specialism is general haematology and her areas of interest include thalaassaemia major, thalassaemia intermedia, iron overload disorders, haemachromatosis and iron deficiency. She leads the service at one of the largest centres for thalassaemia in the Uk and is recognised as an expert for these conditions internationally.

Dr Shah graduated from the University of Punjab in 1994 with an MBBS degree. She became a Member of the Royal College of Physicians in 1997 and a Member of the Royal College of Pathologists in 2001. She completed a Doctorate of Medicine in 2008 at University College London.

In addition, Dr Shah is also actively involved in clinical trials in thalassaemia and sickle cell disease. She has been a Chief Investigator and Primary investigator for a number of clinical trials in both disorders. She has also written book chapters and has published widely in peer-reviewed journals. Dr Shah is also the Chair of the UK Forum on Haemoglobin Disorders which is a multiprofessional organisation that advocates on behalf of patients with haemoglobinopathies. and the current Chair of the National haemoglobinopathy registry.


Diseases, Medical Tests and Treatments
  • Video Consultation
  • Sickle Cell Anaemia
  • Coagulation Disorders
  • Thalassaemia
  • Anaemia
Read more